Skeletal muscle wasting, i.e. the decline of skeletal muscle mass, can occur in various circumstances including: i) long periods of inactivity, e.g. immobilization, ii) denervation, e.g. spinal cord injury, iii) caloric restriction or fasting, iv) during aging, i.e. age-related sarcopenia and v) in many diseases, called cachexia. This reduction of skeletal muscle mass can induce various negative consequences including fatigue, muscle weakness and decreased functional capacity, eventually impairing quality of life. Moreover, in several diseases, muscle atrophy is associated with poor prognosis and can increase morbidity and mortality. Consequently, developing efficient strategies to prevent and/or treat skeletal muscle wasting is extremely i...
Muscle atrophy exacerbates disease outcomes and increases mortality, whereas the preservation of ske...
Abstract Cancer cachexia (CC) is a multifactorial paraneoplastic syndrome characterized by anorexia...
Abstract The syndrome of cachexia, i.e., involuntary weight loss in patients with underlying disease...
Abstract Cancer cachexia is a debilitating consequence of disease progression, characterised by the ...
Loss of skeletal muscle mass occurs during aging (sarcopenia), dis-ease (cachexia), or inactivity (a...
Cachexia is a multifactorial syndrome that presents with, among other characteristics, progressive l...
Cachexia is a clinical condition characterized by muscle wasting, anorexia and metabolic change. It ...
Cachexia is the term used to describe the progressive loss of muscle mass in association with severe...
The present review aimed at discussing the impact, pathogenesis and therapeutic approaches of muscle...
Purpose -- Cancer-induced muscle wasting (i.e., cancer cachexia, CC) is a common and devastating syn...
Cancer cachexia is a debilitating syndrome mainly characterized by muscle and fat wasting, leading t...
Skeletal muscle mass reduction might be a consequence of aging (sarcopenia), disease (cachexia) or i...
The management of cancer patients is frequently complicated by the occurrence of cachexia. This is a...
cancer cachexia is a severe and disabling clinical condition that frequently accompanies the develop...
Purpose of review The aim of the present review is to provide insights into the future therapeutic a...
Muscle atrophy exacerbates disease outcomes and increases mortality, whereas the preservation of ske...
Abstract Cancer cachexia (CC) is a multifactorial paraneoplastic syndrome characterized by anorexia...
Abstract The syndrome of cachexia, i.e., involuntary weight loss in patients with underlying disease...
Abstract Cancer cachexia is a debilitating consequence of disease progression, characterised by the ...
Loss of skeletal muscle mass occurs during aging (sarcopenia), dis-ease (cachexia), or inactivity (a...
Cachexia is a multifactorial syndrome that presents with, among other characteristics, progressive l...
Cachexia is a clinical condition characterized by muscle wasting, anorexia and metabolic change. It ...
Cachexia is the term used to describe the progressive loss of muscle mass in association with severe...
The present review aimed at discussing the impact, pathogenesis and therapeutic approaches of muscle...
Purpose -- Cancer-induced muscle wasting (i.e., cancer cachexia, CC) is a common and devastating syn...
Cancer cachexia is a debilitating syndrome mainly characterized by muscle and fat wasting, leading t...
Skeletal muscle mass reduction might be a consequence of aging (sarcopenia), disease (cachexia) or i...
The management of cancer patients is frequently complicated by the occurrence of cachexia. This is a...
cancer cachexia is a severe and disabling clinical condition that frequently accompanies the develop...
Purpose of review The aim of the present review is to provide insights into the future therapeutic a...
Muscle atrophy exacerbates disease outcomes and increases mortality, whereas the preservation of ske...
Abstract Cancer cachexia (CC) is a multifactorial paraneoplastic syndrome characterized by anorexia...
Abstract The syndrome of cachexia, i.e., involuntary weight loss in patients with underlying disease...